Zotatifin : Targeting eIF4A triggers an interferon response to synergize with chemotherapy and suppress triple-negative breast cancer
| ACY-738 : HDAC6 inhibition reverses axonal transport defects in motor neurons derived from FUS-ALS patients
|
Batimastat: Shifting the balance of activating and inhibitory natural killer receptor ligands on BRAF V600E melanoma lines with vemurafenib
ML162: Connection between the Plasma Level of Apelin and Diabetic Nephropathy in Type 2 Diabetic Patients. A Case Control Study